Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 13;6(1):35-45.
doi: 10.1016/j.cdtm.2020.02.002. eCollection 2020 Mar.

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy

Li-Min Liu  1 , Li-Shui Shen  1 , Shang-Yu Liu  1 , Bin Tu  1 , Guo-Liang Li  2 , Feng Hu  1 , Zhi-Cheng Hu  1 , Ling-Min Wu  1 , Xiao-Han Fan  1 , Li-Hui Zheng  1 , Li-Gang Ding  1 , Yan Yao  1
Affiliations

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy

Li-Min Liu et al. Chronic Dis Transl Med. .

Abstract

Background: Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic obstructive cardiomyopathy (HOCM). Data regarding the correlations of thyroid dysfunction and the incidence of AF in HOCM are quite limited. This study aimed to reveal the correlations between different thyroid status and the corresponding incidence of AF in a large HOCM cohort.

Methods: A total of 806 HOCM patients with complete information on thyroid function tests and comprehensive cardiac evaluations were recruited. The participants were divided into the AF group (n = 159) and non-AF group (n = 647) according to established medical history and results of Holter monitoring. The thyroid status of the study population and the corresponding incidence of AF were assessed and analyzed.

Results: Hypothyroidism accounted for the greatest proportion of thyroid dysfunction in HOCM patients. The incidence of AF significantly increased in individuals with both overt (P = 0.022) and subclinical (P = 0.007) hypothyroidism. Compared with participants in the non-AF group, those with positive AF episodes presented with lower free triiodothyronine (FT3) (2.86 ± 0.52 pg/mL vs. 3.01 ± 0.42 pg/mL, P = 0.001), higher free thyroxine (FT4) (1.24 ± 0.25 ng/dL vs. 1.15 ± 0.16 ng/dL, P < 0.001), and remarkably increased levels of thyrotropin (TSH) (12.6% vs. 5.3%, P = 0.001). Multivariable analyses demonstrated that the concentrations of FT3 (odds ratio [OR] = 0.470, 95% confidence interval [CI]: 0.272-0.813, P = 0.007) and FT4 (OR = 17.992, 95% CI: 5.750-56.296, P < 0.001), as well as TSH levels above normal ranges (OR = 2.276, 95% CI: 1.113-4.652, P = 0.024) were independently associated with the occurrence of AF in the large HOCM cohort.

Conclusions: This study indicated a strong link between low thyroid function and the presence of AF in HOCM. Hypothyroidism (both overt and subclinical states) seems to be valuable for assessing the incidence of AF in patients with HOCM.

Keywords: Atrial fibrillation; Hypertrophic obstructive cardiomyopathy; Hypothyroidism; Thyroid hormone.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Distribution of thyroid status (A) and incidence of AF (B) in the HOCM cohort. HOCM: hypertrophic obstructive cardiomyopathy; AF: atrial fibrillation; T3: triiodothyronine.
Fig. 2
Fig. 2
Incidence of AF according to the levels of FT3 (A), FT4 (B) and TSH (C). AF: atrial fibrillation; FT3: free triiodothyronine; FT4: free thyroxine; TSH: thyrotropin.
See this image and copyright information in PMC

References

    1. Maron B.J., Maron M.S. Hypertrophic cardiomyopathy. Lancet. 2012;381:9862. - PubMed
    1. Maron B.J. Hypertrophic cardiomyopathy: a systemic review. J Am Med Assoc. 2002;287:1308–1320. - PubMed
    1. Prinz C., Farr M., Hering D., Horstkotte D., Faber L. The diagnosis and treatment of hypertrophic cardiomyopathy. Dtsch Arztebl Int. 2011;108:209–215. http://www.ncbi.nlm.nih.gov/pubmed/21505608 - PMC - PubMed
    1. Guttmann O.P., Rahman M.S., O'Mahony C., Anastasakis A., Elliott P.M. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014;100:465–472. - PubMed
    1. Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517–2524. - PubMed